{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:39:32Z","timestamp":1770835172002,"version":"3.50.1"},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.8013","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T18:11:36Z","timestamp":1493575896000},"page":"1095-1099","source":"Crossref","is-referenced-by-count":19,"title":["Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions"],"prefix":"10.2169","volume":"56","author":[{"given":"Hiroki","family":"Mochizuki","sequence":"first","affiliation":[{"name":"Internal Medicine, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manako","family":"Kato","sequence":"additional","affiliation":[{"name":"Internal Medicine, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takakazu","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Koyamada","sequence":"additional","affiliation":[{"name":"Division of Hematology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadamu","family":"Okada","sequence":"additional","affiliation":[{"name":"Division of Hematology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Eto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet 385: 1460-1471, 2015.","DOI":"10.1016\/S0140-6736(14)60720-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25: 1181-1192, 2012.","DOI":"10.1038\/modpathol.2012.72"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheum 67: 1688-1699, 2015.","DOI":"10.1002\/art.39132"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease. Clinical and laboratory features in one hundred twenty-five patients. Arthtitis Rheum 67: 2466-2475, 2015.","DOI":"10.1002\/art.39205"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine 94: e680, 2015.","DOI":"10.1097\/MD.0000000000000680"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miyagawa-Hayashino A, Matsumura Y, Kawakami F, et al. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis -is this a cutaneous manifestation of IgG4-related disease? Human Pathol 40: 1269-1277, 2009.","DOI":"10.1016\/j.humpath.2009.01.013"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kempeneers D, Hauben E, De Haes P. IgG4-related skin lesions: case report and review of the literature. Clin Exp Dermatol 39: 479-483, 2014.","DOI":"10.1111\/ced.12325"},{"key":"8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1634\/theoncologist.2010-0212","volume":"16","author":"H El-Osta","year":"2011","unstructured":"8. El-Osta H, Kurzrock R. Castleman's disease: from basic mechanisms to molecular therapeutics. The Oncologist 16: 497-511, 2011.","journal-title":"The Oncologist","ISSN":"https:\/\/id.crossref.org\/issn\/1083-7159","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Stone JH, Brito-Zer\u00f3n P, Bosch X, Ramos-Casals M. Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin Proc 90: 927-939, 2015.","DOI":"10.1016\/j.mayocp.2015.03.020"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sato Y, Kojima M, Takata K, et al. Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol 63: 1084-1089, 2010.","DOI":"10.1136\/jcp.2010.082958"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Ogoshi T, Kido T, Yatera K, et al. Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease. Lung 191: 575-583, 2013.","DOI":"10.1007\/s00408-013-9497-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sato Y, Kojima M, Tanaka K, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol 22: 589-599, 2009.","DOI":"10.1038\/modpathol.2009.17"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum 43: 806-817, 2014.","DOI":"10.1016\/j.semarthrit.2013.11.008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Cuur Opin Rheumatol 23: 67-71, 2011.","DOI":"10.1097\/BOR.0b013e328341a240"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease. Lessons from 10 consecutive patients. Medicine 91: 57-66, 2012.","DOI":"10.1097\/MD.0b013e3182431ef6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 74: 1171-1177, 2015.","DOI":"10.1136\/annrheumdis-2014-206605"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood 123: 2924-2933, 2014.","DOI":"10.1182\/blood-2013-12-545087"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Takeuchi M, Sato Y, Takata K, et al. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease. Pathol Res Pract 208: 746-749, 2012.","DOI":"10.1016\/j.prp.2012.09.006"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sato Y, Takeuchi M, Takata K, et al. Clinicopathologic analysis of IgG4-related skin disease. Mod Pathol 26: 523-532, 2013.","DOI":"10.1038\/modpathol.2012.196"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Charrow A, Imadojemu S, Stephen S, Ogunleye T, Takeshita J, Lipoff JB. Cutaneous manifestations of IgG4-related disease (RD): a systematic review. J Am Acad Dermatol 75: 197-202, 2016.","DOI":"10.1016\/j.jaad.2016.01.046"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Alamino RP, Espinoza LR, Zea AH. The great mimicker: IgG-related disease. Clin Rheumatol 32: 1267-1273, 2013.","DOI":"10.1007\/s10067-013-2326-z"},{"key":"22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/eye.1993.18","volume":"7","author":"MP Snead","year":"1993","unstructured":"22. Snead MP, James JN, Snead DRJ, Robson DK, Rizk SNM. Orbital lymphomas and Castleman's disease. Eye 7: 84-88, 1993.","journal-title":"Eye","ISSN":"https:\/\/id.crossref.org\/issn\/0078-5334","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Koppens JM, Pon JM, Allen J, Sloan BH. Castleman's disease of the lacrimal gland. Clin Experiment Ophthalmol 32: 108-110, 2004.","DOI":"10.1046\/j.1442-9071.2004.00771.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hirt R, Krause U, Knipping S. M. Castleman. Eine seltene Differenzialdiagnose zum Heerfordt-Syndrom. HNO 60: 1123-1126, 2012 (in German, Abstract in English).","DOI":"10.1007\/s00106-012-2522-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 33: 1886-1893, 2009.","DOI":"10.1097\/PAS.0b013e3181bd535b"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology 251: 260-270, 2009.","DOI":"10.1148\/radiol.2511080965"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Fei Y, Shi J, Lin W, et al. Intrathoracic involvements of immunoglobulin G4-related sclerosing disease. Medicine 94: e2150, 2015.","DOI":"10.1097\/MD.0000000000002150"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sun X, Liu H, Feng R, et al. Biopsy-proven IgG4-related lung disease. BMC Pulm Med 16: 20, 2016.","DOI":"10.1186\/s12890-016-0181-9"},{"key":"29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1148\/radiology.209.2.9807577","volume":"209","author":"T Johkoh","year":"1998","unstructured":"29. Johkoh T, M\u00fcller NL, Ichikado K, et al. Intrathoracic multicentric Castleman disease: CT findings in 12 patients. Radiology 209: 477-481, 1998.","journal-title":"Radiology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-8419","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/9\/56_56.8013\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T11:44:55Z","timestamp":1498391095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/9\/56_56.8013\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.8013","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}